Titre:
  • A two arm phase II study of FOLFIRI in combination with standard or escalating dose of cetuximab as first line treatment for metastatic colorectal cancer: Everest 2 final results
Auteur:Chiritescu, Gabriela; Dumon, Kristien; Mercade, Teresa Macarulla; Lang, I.; Vivas, Cristina Santos; Papai, Zsuzsanna; Janssens, Jos; Hendrickx, Koen; Pracht, Marc; Van Den Eynde, Marc; Taieb, Julien; Moons, Veerle; Geboes, K.; Van Laethem, Jean-Luc; Greil, Richard; Cervantes, Andrés; Vergauwe, Philippe; Ferrante, Michel; Vanderstraeten, Erik; Fridrik, Michael; Wöll, Ernst; Limón, María Luisa M.; Rivera, Fernando; Sagaert, Xavier; Tejpar, Sabine; Van Cutsem, Eric
Informations sur la publication:Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, 29, page (v105)
Statut de publication:Publié, 2018-06
Sujet CREF:Cancérologie
Hématologie
Note générale:SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:1569-8041
info:doi/10.1093/annonc/mdy149.014
info:pii/S0923753419337019
info:scp/85078067015
info:pmid/32176994